Evofem Biosciences: In The Original Report To Correctly Link The Certificate Of Designation Of The Series F1 Preferred Stock. No Other Amendments Or Modifications To The Original Report Are Being Made By This Amendment. This Amendment Should Be Read In Connection With The Original Report, Which Provides A More Complete Description Of The Merger Agreement And Merger Contemplated Thereby

Show full article

This functionality is available for registred users only

• Full name
  Evofem Biosciences Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***